COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 2 for:    ipilimumab sipuleucel | Prostate Cancer
Previous Study | Return to List | Next Study

Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01832870
Recruitment Status : Completed
First Posted : April 16, 2013
Last Update Posted : August 24, 2017
Information provided by (Responsible Party):
Prostate Oncology Specialists, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2016
Actual Study Completion Date : February 2016